The lung is the preferred site of metastasis from soft tissue sarcoma (STS). This systematic review aims to evaluate the outcomes of stereotactic body radiotherapy (SBRT) and metastasectomy (MTS) for the treatment of lung metastases from STS. A systematic review was carried out according to the PRISMA protocol. PubMed, Medline, EMBASE, Cochrane Library, Ovid and Web of Knowledge databases were searched for English-language articles to December 2018 using a predefined strategy. Retrieved studies were independently screened and rated for relevance. Data were extracted by two researchers. In total, there were 1306 patients with STS: 1104 underwent MTS and 202 had SBRT. The mean age ranged from 40 to 55.8 years in the MTS group and from 47.9 to...
Background and purpose: Stereotactic ablative radiotherapy (SABR; or stereotactic body radiotherapy,...
Background: Surgery and stereotactic body radiotherapy (SBRT) are two of the options available as lo...
Purpose: The aim of this study was to evaluate prognostic factors in patients with lung metastases w...
The lung is the preferred site of metastasis from soft tissue sarcoma (STS). This systematic review ...
Background: Radio-frequency ablation (RFA) and Stereotactic Body Radiation Therapy (SBRT) are two em...
Background: Radio-frequency ablation (RFA) and Stereotactic Body Radiation Therapy (SBRT) are two em...
BACKGROUND: The purpose of this study was to evaluate local control and toxicity in a group of pati...
Introduction. Patients with high-grade sarcoma (HGS) frequently develop metastatic disease thus limi...
Background. The most common site of sarcoma metastasis is the lung. Surgical resection of pulmonary ...
It is not clear as to which is the best treatment among surgery and stereotactic radiotherapy (SBRT)...
INTRODUCTION: Isolated pulmonary metastases from soft tissue sarcomas occur in 20-50% of these(the i...
Lung metastases are the second most common malignant neoplasms of the lung. It is estimated that 20–...
Stereotactic body radiation therapy (SBRT) has an emerging role in patients affected with pulmonary ...
Background and purpose: Stereotactic ablative radiotherapy (SABR; or stereotactic body radiotherapy,...
Background and purpose: Stereotactic ablative radiotherapy (SABR; or stereotactic body radiotherapy,...
Background: Surgery and stereotactic body radiotherapy (SBRT) are two of the options available as lo...
Purpose: The aim of this study was to evaluate prognostic factors in patients with lung metastases w...
The lung is the preferred site of metastasis from soft tissue sarcoma (STS). This systematic review ...
Background: Radio-frequency ablation (RFA) and Stereotactic Body Radiation Therapy (SBRT) are two em...
Background: Radio-frequency ablation (RFA) and Stereotactic Body Radiation Therapy (SBRT) are two em...
BACKGROUND: The purpose of this study was to evaluate local control and toxicity in a group of pati...
Introduction. Patients with high-grade sarcoma (HGS) frequently develop metastatic disease thus limi...
Background. The most common site of sarcoma metastasis is the lung. Surgical resection of pulmonary ...
It is not clear as to which is the best treatment among surgery and stereotactic radiotherapy (SBRT)...
INTRODUCTION: Isolated pulmonary metastases from soft tissue sarcomas occur in 20-50% of these(the i...
Lung metastases are the second most common malignant neoplasms of the lung. It is estimated that 20–...
Stereotactic body radiation therapy (SBRT) has an emerging role in patients affected with pulmonary ...
Background and purpose: Stereotactic ablative radiotherapy (SABR; or stereotactic body radiotherapy,...
Background and purpose: Stereotactic ablative radiotherapy (SABR; or stereotactic body radiotherapy,...
Background: Surgery and stereotactic body radiotherapy (SBRT) are two of the options available as lo...
Purpose: The aim of this study was to evaluate prognostic factors in patients with lung metastases w...